The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure, sparing a critical patient open-heart surgery with a device therapy: a case report.

Journal: European heart journal. Case reports
Published Date: Dec 29, 2020

Abstract

BACKGROUND: Timely use of Sacubitril/Valsartan has the potential to significantly improve cardiac function and dramatically reduce secondary mitral regurgitation (MR) severity even in patients presenting with acute decompensated heart failure (HF), not only in compensated chronic HF patients. The outstanding impact of echocardiography is obvious in monitoring improvement of cardiac function and MR severity in patients with HF with reduced ejection fraction (HFrEF).

Authors

  • Fady Gerges
    Department of Cardiovascular Sciences, NMC Specialty Hospital, Cardiology Clinic, Al Ain, Postal code P.O. Box 84142,United Arab Emirates.
  • Austin Komaranchath
    Department of Cardiovascular Sciences, NMC Specialty Hospital, Cardiology Clinic, Al Ain, Postal code P.O. Box 84142,United Arab Emirates.
  • Faiz Al Bakshy
    Department of Cardiology, Mediclinic Al-Ain hospital,United Arab Emirates.
  • Abdallah Almaghraby
    Department of Cardiology, University of Alexandria,Egypt.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals